University of Manchester
Manchester, United Kingdom
Purpose
To evaluate enzyme-based methods to reduce the cost of a chemical intermediate in Lenacapavir synthesis, enabling affordable generic HIV treatment access in low- and middle-income countries.
Division
Global Health
Date
September 2025
Region Served
GLOBAL
Committed amount
$1,075,272
Grant topic
Development of Solutions to Improve Global Health, HIV
Duration (months)
23
Grantee location
Manchester, United Kingdom
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.